Cancer T Cell Immunotherapy with Bispecific Antibodies and Chimeric Antigen Receptors

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 8, Iss. 3, 2013-09 ,pp. : 239-254

Bentham Science Publishers

Access to resources Recommend Favorite

The contribution of dendritic cells to immune responses against urological cancers - T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen

By Troy A.   Davidson P.   Atkinson C.   Hart D.  

Urologic Oncology: Seminars and Original Investigations, Vol. 4, Iss. 1, 1998-01 ,pp. : 17-23

Elsevier

Access to resources Recommend Favorite

Enhanced central memory cluster of differentiation 8+ and tumor antigen-specific T cells in prostate cancer patients receiving repeated in situ adenovirus-mediated suicide gene therapy

By                

Molecular and Clinical Oncology, Vol. 3, Iss. 3, 2015-01 ,pp. : 515-521

Science Publishers

Access to resources Recommend Favorite

Enhancement of the Adenoviral Sensitivity of Human Ovarian Cancer Cells by Transient Expression of Coxsackievirus and Adenovirus Receptor (CAR)

By Kim J-S.   Lee S-H.   Cho Y-S.   Choi J-J.   Kim Y.H.   Lee J-H.  

Gynecologic Oncology, Vol. 85, Iss. 2, 2002-05 ,pp. : 260-265

Academic Press

Access to resources Recommend Favorite

H1 histamine receptor antagonist inhibits constitutive growth of Jurkat T cells and antigen-specific proliferation of ovalbumin-specific murine T cells

By Radvány Z.   Darvas Z.   Kerekes K.   Prechl J.   Szalai C.   Pállinger E.   Valéria L.   Lia Varga V.   Sandor M.   Erdei A.   Falus A.  

Seminars in Cancer Biology, Vol. 10, Iss. 1, 2000-02 ,pp. : 41-45

Academic Press

Access to resources Recommend Favorite